Home LiteratureArticle Details
PMID: 11095842 Published · ppublish English Journal Article

Probiotics in the Treatment of Diarrheal Diseases.

Current infectious disease reports ·Vol. 2 ·No. 1 ·2000-02-00 ·Pages 78

Reid G

Abstract

Infections of the gastrointestinal tract are a major health problem worldwide, and many result in death, especially in the Third World. The approach to treatment and prevention of these infections has revolved around antibiotic administration for many years, but the emergence of multidrug-resistant pathogens is forcing people to look at alternatives to antibiotics. For more than 100 years, probiotic remedies (viable organisms that benefit the host by improving the microbial balance) have been used to fight infection. Now, substantial scientific and clinical evidence indicates that certain well-selected probiotic organisms can reduce the risk and duration of diarrhea.

Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Reid
H414, Lawson Research Institute, 268 Grosvenor Street, London, Ontario, N6A 4V2, Canada. [email protected]
References (39)
39 references, click to expand
  1. Modulation of nonspecific mechanisms of defense by lactic acid bacteria: effective dose.
    J Dairy Sci. 1999 May;82(5):863-9 PMID: 10342225
  2. The Lactobacillus anomaly: total iron abstinence.
    Perspect Biol Med. 1997 Summer;40(4):578-83 PMID: 9269745
  3. Immunonutrition: role of biosurfactants, fiber, and probiotic bacteria.
    Nutrition. 1998 Jul-Aug;14(7-8):585-94 PMID: 9684261
  4. Effect of ecological factors on the inhibitory spectrum and activity of bacteriocins.
    Int J Food Microbiol. 1999 Feb 18;46(3):207-17 PMID: 10100901
  5. Differentiation of Lactobacillus Species by Molecular Typing.
    Appl Environ Microbiol. 1998 Jul 1;64(7):2418-23 PMID: 9647809
  6. [Combined antibacterial and probiotic therapy of Helicobacter-associated diseases in children].
    Zh Mikrobiol Epidemiol Immunobiol. 1999 Mar-Apr;(2):76-81 PMID: 10356744
  7. Immune modulation of blood leukocytes in humans by lactic acid bacteria: criteria for strain selection.
    Am J Clin Nutr. 1997 Aug;66(2):515S-520S PMID: 9250141
  8. [Estimation of probiotics by infection model of infant rabbit with enterohemorrhagic Escherichia coli O157:H7].
    Kansenshogaku Zasshi. 1998 Dec;72(12):1300-5 PMID: 9916417
  9. Lactobacilli isolated from chicken intestines: potential use as probiotics.
    J Food Prot. 1999 Mar;62(3):252-6 PMID: 10090244
  10. The ability of probiotic bacteria to bind to human intestinal mucus.
    FEMS Microbiol Lett. 1998 Oct 15;167(2):185-9 PMID: 9809419
  11. Interference in initial adhesion of uropathogenic bacteria and yeasts to silicone rubber by a Lactobacillus acidophilus biosurfactant.
    J Med Microbiol. 1998 Dec;47(12):1081-5 PMID: 9856644
  12. The scientific basis for probiotic strains of Lactobacillus.
    Appl Environ Microbiol. 1999 Sep;65(9):3763-6 PMID: 10473372
  13. Lactic acid bacterium potently induces the production of interleukin-12 and interferon-gamma by mouse splenocytes.
    Int J Immunopharmacol. 1999 Feb;21(2):121-31 PMID: 10230875
  14. Prebiotics and synbiotics: concepts and nutritional properties.
    Br J Nutr. 1998 Oct;80(4):S197-202 PMID: 9924284
  15. Probiotic spectra of lactic acid bacteria (LAB).
    Crit Rev Food Sci Nutr. 1999 Jan;39(1):13-126 PMID: 10028126
  16. Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice.
    Gastroenterology. 1999 May;116(5):1107-14 PMID: 10220502
  17. Probiotics and E. coli infections in man.
    Vet Q. 1998;20 Suppl 3:S78-81 PMID: 9689732
  18. Enterococci at the crossroads of food safety?
    Int J Food Microbiol. 1999 Mar 1;47(1-2):1-24 PMID: 10357269
  19. Adhesion of some probiotic and dairy Lactobacillus strains to Caco-2 cell cultures.
    Int J Food Microbiol. 1998 May 5;41(1):45-51 PMID: 9631336
  20. A microbiology investigation on probiotic pharmaceutical products used for human health.
    Microbiol Res. 1997 Jul;152(2):171-9 PMID: 9265768
  21. Ingestion of yogurt containing Lactobacillus acidophilus and Bifidobacterium to potentiate immunoglobulin A responses to cholera toxin in mice.
    J Dairy Sci. 1999 Apr;82(4):649-60 PMID: 10212452
  22. Survival of a probiotic, Lactobacillus casei strain Shirota, in the gastrointestinal tract: selective isolation from faeces and identification using monoclonal antibodies.
    Int J Food Microbiol. 1999 Apr 1;48(1):51-7 PMID: 10375134
  23. Taxonomy and physiology of probiotic lactic acid bacteria.
    Int J Food Microbiol. 1998 May 26;41(2):103-25 PMID: 9704860
  24. Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children.
    Int J Food Microbiol. 1998 Jun 30;42(1-2):39-44 PMID: 9706796
  25. Antibiotic susceptibility of potentially probiotic Lactobacillus species.
    J Food Prot. 1998 Dec;61(12):1636-43 PMID: 9874341
  26. Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis.
    Pediatr Infect Dis J. 1997 Dec;16(12):1103-7 PMID: 9427453
  27. Lactic acid-mediated suppression of Helicobacter pylori by the oral administration of Lactobacillus salivarius as a probiotic in a gnotobiotic murine model.
    Am J Gastroenterol. 1998 Nov;93(11):2097-101 PMID: 9820379
  28. The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans.
    Eur J Clin Nutr. 1998 Dec;52(12):899-907 PMID: 9881885
  29. Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children.
    J Pediatr Gastroenterol Nutr. 1997 Apr;24(4):399-404 PMID: 9144122
  30. A placebo-controlled trial of Lactobacillus GG to prevent diarrhea in undernourished Peruvian children.
    J Pediatr. 1999 Jan;134(1):15-20 PMID: 9880443
  31. Isolation and identification of lactobacilli from novel-type probiotic and mild yoghurts and their stability during refrigerated storage.
    Int J Food Microbiol. 1999 Mar 1;47(1-2):79-87 PMID: 10357276
  32. The lack of therapeutic effect of Saccharomyces boulardii in the prevention of antibiotic-related diarrhoea in elderly patients.
    J Infect. 1998 Mar;36(2):171-4 PMID: 9570649
  33. Development of consumer probiotics for the US market.
    Br J Nutr. 1998 Oct;80(4):S213-8 PMID: 9924287
  34. Antibacterial activity of Lactobacillus species against Vibrio species.
    Microbiol Res. 1998 Nov;153(3):271-5 PMID: 9880930
  35. Probiotic fermented food mixtures: possible applications in clinical anti-diarrhoea usage.
    Nutr Health. 1998;12(2):97-105 PMID: 9502235
  36. Immunomodulation by treatment with Lactobacillus casei strain Shirota.
    Int J Food Microbiol. 1998 May 26;41(2):133-40 PMID: 9704862
  37. Survival of Lactobacillus plantarum DSM 9843 (299v), and effect on the short-chain fatty acid content of faeces after ingestion of a rose-hip drink with fermented oats.
    Int J Food Microbiol. 1998 Jun 30;42(1-2):29-38 PMID: 9706795
  38. Antagonistic action of cells of Lactobacillus lactis toward Escherichia coli O157:H7 on refrigerated raw chicken meat.
    J Food Prot. 1998 Feb;61(2):166-70 PMID: 9708275
  39. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression.
    Am J Physiol. 1999 Apr;276(4 Pt 1):G941-50 PMID: 10198338
Article Info
Journal
Current infectious disease reports
Abbr.
Curr Infect Dis Rep
ISSN
1523-3847
DOI
10.1007/s11908-000-0092-y
Email
[email protected]
Published
2000-02-00
Pages
78
Language
English
Region
United States
NLM ID
100888983
External Links
PubMed source DOI: 10.1007/s11908-000-0092-y View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2